NCT01768260

Effect of EECP on Anterior Ischemic Optic Neuropathy

Study of the Effect of EECP on Anterior Ischemic Optic Neuropathy

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: First Affiliated Hospital, Sun Yat-Sen University · Academic / Other
• Sex: All
• Age: 40 Years – 80 Years
• Healthy volunteers: Accepted

Summary

Enhanced External Counterpulsation(EECP) therapy may promote the recovery of visual function by improving the blood perfusion of eyes. The present study aims to investigate the effect of EECP on Anterior Ischemic Optic Neuropathy.

Detailed description

Patients with Anterior Ischemic Optic Neuropathy are randomized into two groups: one group receive standard medical treatment for ischemic optic neuropathy, the other group plus EECP therapy besides standard medical treatment.

Conditions

• Anterior Ischemic Optic Neuropathy

Interventions

Type	Name	Description
DEVICE	Enhanced external counterpulsation	EECP is performed for 1 hours every day, for a total of 36 hours.
DRUG	Aspirin	Standard drug therapy

Timeline

• Start date: 2012-12-01
• Primary completion: 2017-12-01
• Completion: 2018-03-01
• First posted: 2013-01-15
• Last updated: 2017-03-31

Locations

1 site across 1 country: China